跨性别人口中的癌症和心脏毒性
1Departamento de Cardio-Oncología, Centro Estatal de Cancerología "Miguel Dorantes Mesa", Xalapa, Veracruz, México.
Archivos de cardiologia de Mexico
|November 22, 2023
概括
癌症患者面临显著更高的心血管疾病风险. 解决差异和研究缺口,特别是像LGBTQ社区这样的边缘化群体,对于改善癌症和心脏健康结果至关重要.
科学领域:
- 在瘤学瘤学.
- 心脏病学 心脏病学
- 健康差异 在健康上的差异
背景情况:
- 与普通人群相比,新诊断的癌症患者患心血管疾病的死亡风险高2-6倍.
- 癌症治疗 (化疗,放射治疗) 的心血管并发症和医疗保健准入问题使数据收集复杂化,特别是在边缘化社区.
- 在LGBTQ社区经历独特的癌症风险和考虑,包括激素治疗性别肯定,需要定制的研究.
研究的目的:
- 突出癌症诊断和心血管疾病之间的复杂相互作用.
- 为了强调癌症患者心血管死亡风险的增加.
- 识别研究差距和差异,以了解边缘化群体内心脏毒性,包括LGBTQ和跨性别社区.
主要方法:
- 文献综述和综合有关癌症流行病学和心血管风险的现有数据.
- 分析与治疗相关的心脏毒性及其影响.
- 检查影响边缘化人口的健康和医疗保健获取的社会决定因素.
主要成果:
- 癌症患者面临冠状动脉疾病,心力衰竭和心房的风险增加.
- 在边缘化群体的癌症和心脏毒性数据收集中存在显著差异.
- 跨性别人口中癌症和心脏毒性研究有限,这表明需要进一步调查.
结论:
- 癌症和心血管疾病之间的联系需要全面的管理策略.
- 迫切需要注意解决数据缺口,并制定针对癌症和心脏毒性在脆弱人群中的向检测和预防策略.
- 进一步的研究对于理解和减轻与LGBTQ和跨性别社区癌症及其治疗相关的特定心血管风险至关重要,包括荷尔蒙依赖性瘤.
相关概念视频
What is Cancer?
10.8K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
10.8K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Psychoneuroimmunology: Diabetes and Cancer
30
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
30
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K


